Get started
DR. HOENLE AG O.N.DR. HOENLE AG O.N.DR. HOENLE AG O.N.

DR. HOENLE AG O.N.

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

HNL chart


Full chart

HNL upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪54.07 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.88 EUR
Net income (FY)
‪−11.01 M‬ EUR
Revenue (FY)
‪106.34 M‬ EUR
Shares float
‪3.75 M‬
Beta (1Y)
0.36

Employees


Employees (FY)
594
Change (1Y)
−54 −8.33%
Revenue / Employee (1Y)
‪189.25 K‬ EUR
Net income / Employee (1Y)
‪−20.17 K‬ EUR

About DR HOENLE AG


Sector
Producer Manufacturing
Industry
Electrical Products
CEO
Markus Arendt
Website
hoenle.de
Headquarters
Gilching
Founded
1976
ISIN
DE0005157101
FIGI
BBG000F69SG1
Dr. Hönle AG engages in the development, manufacture, and sale of light-emitting diode ultraviolet products. It operates through the following segments: Equipment and Systems, Adhesives, and Glass and Lamps. The Equipment and Systems segment offers UV products that are used for drying inks and coatings, curing adhesives and plastics, disinfecting surfaces, and sunlight simulation. The Adhesives segment develops, produces, and sells adhesives. The Glass and Lamps segment includes the development, production, and sale of tubing and semi-finished goods made of quartz glass as well as the manufacture of UV medium-pressure and low-pressure lamps. The company was founded by Karl Hönle and Günter Schmid in 1976 and is headquartered in Gilching, Germany.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

HNL news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of HNL is 8.64 EUR — it has decreased by −0.22% in the past 24 hours. Watch DR. HOENLE AG O.N. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange DR. HOENLE AG O.N. stocks are traded under the ticker HNL.
HNL stock has risen by 2.30% compared to the previous week, the month change is a −17.97% fall, over the last year DR. HOENLE AG O.N. has showed a −50.34% decrease.
We've gathered analysts' opinions on DR. HOENLE AG O.N. future price: according to them, HNL price has a max estimate of 26.50 EUR and a min estimate of 19.00 EUR. Watch HNL chart and read a more detailed DR. HOENLE AG O.N. stock forecast: see what analysts think of DR. HOENLE AG O.N. and suggest that you do with its stocks.
HNL reached its all-time high on Jul 31, 2018 with the price of 88.80 EUR, and its all-time low was 1.66 EUR and was reached on Dec 20, 2002. View more price dynamics on HNL chart.
See other stocks reaching their highest and lowest prices.
HNL stock is 0.46% volatile and has beta coefficient of 0.36. Track DR. HOENLE AG O.N. stock price on the chart and check out the list of the most volatile stocks — is DR. HOENLE AG O.N. there?
Today DR. HOENLE AG O.N. has the market capitalization of ‪54.07 M‬, it has decreased by −0.45% over the last week.
Yes, you can track DR. HOENLE AG O.N. financials in yearly and quarterly reports right on TradingView.
DR. HOENLE AG O.N. is going to release the next earnings report on Dec 6, 2024. Keep track of upcoming events with our Earnings Calendar.
HNL net income for the last quarter is ‪−265.00 K‬ EUR, while the quarter before that showed ‪181.00 K‬ EUR of net income which accounts for −246.41% change. Track more DR. HOENLE AG O.N. financial stats to get the full picture.
As of Nov 22, 2024, the company has 594.00 employees. See our rating of the largest employees — is DR. HOENLE AG O.N. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DR. HOENLE AG O.N. EBITDA is ‪6.82 M‬ EUR, and current EBITDA margin is −0.77%. See more stats in DR. HOENLE AG O.N. financial statements.
Like other stocks, HNL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DR. HOENLE AG O.N. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DR. HOENLE AG O.N. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DR. HOENLE AG O.N. stock shows the sell signal. See more of DR. HOENLE AG O.N. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.